|
|
Article: Research from Nanjing Medical University in the area of heart attack published.
- Article from:
- Heart Disease Weekly
- Article date:
- November 15, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
According to recent research from Nanjing, People's Republic of China, "Mesenchymal stem cells (MSCs)-based regenerative therapy is currently regarded as an alternative approach to salvage the acute myocardial infarcted hearts. However, the efficiency of MSCs transplantation is limited by lower survival rate of engrafted MSCs."
"In previous study, we found that 1.0 mu g/ml Lipopolysaccharide (LPS) could protect MSCs against apoptosis induced by oxidative stress and meanwhile enhance the proliferation of MSCs. Therefore, in the present study, we firstly preconditioned MSCs with 1.0 mu g/ml LPS, then transplanted MSCs into ischemic myocardium, and observed the ...
Related newspaper, magazine, and journal articles:
|
|
Article: Nanjing Medical University reports research ...
Blood Weekly;
February 19, 2009 ;
700+ words
... ... Yu and colleagues, Nanjing Medical University (see also Kidney Transplants ... contact B. Zhang, Nanjing Medical University, Affiliated Hospital ... Transplantation, Treatment, Nanjing Medical University. This article was prepared ...
|
|